DexCom Inc. (DXCM): Price and Financial Metrics
DXCM Price/Volume Stats
Current price | $139.11 | 52-week high | $142.00 |
Prev. close | $139.48 | 52-week low | $74.75 |
Day low | $138.87 | Volume | 1,003,850 |
Day high | $140.80 | Avg. volume | 3,089,358 |
50-day MA | $125.75 | Dividend yield | N/A |
200-day MA | $114.31 | Market Cap | 53.63B |
DXCM Stock Price Chart Interactive Chart >
DXCM POWR Grades
- DXCM scores best on the Quality dimension, with a Quality rank ahead of 91.95% of US stocks.
- The strongest trend for DXCM is in Stability, which has been heading down over the past 26 weeks.
- DXCM ranks lowest in Momentum; there it ranks in the 7th percentile.
DXCM Stock Summary
- DXCM has a market capitalization of $46,469,193,162 -- more than approximately 94.56% of US stocks.
- With a price/earnings ratio of 123.26, DEXCOM INC P/E ratio is greater than that of about 95.06% of stocks in our set with positive earnings.
- The price/operating cash flow metric for DEXCOM INC is higher than 94.96% of stocks in our set with a positive cash flow.
- If you're looking for stocks that are quantitatively similar to DEXCOM INC, a group of peers worth examining would be PODD, DT, FICO, NABL, and ESMT.
- Visit DXCM's SEC page to see the company's official filings. To visit the company's web site, go to www.dexcom.com.
DXCM Valuation Summary
- In comparison to the median Healthcare stock, DXCM's price/sales ratio is 540.91% higher, now standing at 14.1.
- DXCM's price/earnings ratio has moved up 145.4 over the prior 228 months.
Below are key valuation metrics over time for DXCM.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
DXCM | 2023-12-29 | 14.1 | 21.1 | 127.2 | 86.4 |
DXCM | 2023-12-28 | 14.1 | 21.2 | 127.2 | 86.5 |
DXCM | 2023-12-27 | 14.0 | 21.1 | 126.8 | 86.2 |
DXCM | 2023-12-26 | 14.0 | 21.0 | 126.6 | 86.0 |
DXCM | 2023-12-22 | 13.9 | 20.8 | 125.2 | 85.1 |
DXCM | 2023-12-21 | 13.9 | 20.9 | 125.9 | 85.5 |
DXCM Growth Metrics
- Its 3 year net income to common stockholders growth rate is now at 263.1%.
- Its 3 year net cashflow from operations growth rate is now at 238%.
- The 2 year net cashflow from operations growth rate now stands at 59.46%.
The table below shows DXCM's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 2,909.8 | 669.5 | 341.2 |
2022-09-30 | 2,792.8 | 642.8 | 230 |
2022-06-30 | 2,673.4 | 596.9 | 199.7 |
2022-03-31 | 2,572.3 | 485.7 | 211.7 |
2021-12-31 | 2,448.5 | 442.5 | 154.7 |
2021-09-30 | 2,319.2 | 508.7 | 529.3 |
DXCM's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- DXCM has a Quality Grade of B, ranking ahead of 87.89% of graded US stocks.
- DXCM's asset turnover comes in at 0.517 -- ranking 89th of 186 Medical Equipment stocks.
- VRAY, ZYXI, and SRTS are the stocks whose asset turnover ratios are most correlated with DXCM.
The table below shows DXCM's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.517 | 0.693 | 0.081 |
2021-06-30 | 0.510 | 0.692 | 0.077 |
2021-03-31 | 0.506 | 0.675 | 0.070 |
2020-12-31 | 0.547 | 0.664 | 0.077 |
2020-09-30 | 0.597 | 0.654 | 0.089 |
2020-06-30 | 0.651 | 0.639 | 0.090 |
DXCM Price Target
For more insight on analysts targets of DXCM, see our DXCM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $530.60 | Average Broker Recommendation | 1.36 (Strong Buy) |
DexCom Inc. (DXCM) Company Bio
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second generation product, the Seven Continuous Glucose Monitoring System in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment. (Source:Wikipedia)
Latest DXCM News From Around the Web
Below are the latest news stories about DEXCOM INC that investors may wish to consider to help them evaluate DXCM as an investment opportunity.
3 Medical-Device Stocks Could Click in 2024Baird is bullish on Boston Scientific, Insulet, and DexCom, stocks set to benefit as those companies ramp up sales. |
5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024. |
Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)Key Insights Using the 2 Stage Free Cash Flow to Equity, DexCom fair value estimate is US$117 Current share price of... |
DexCom (DXCM) Stock Falls Amid Market Uptick: What Investors Need to KnowIn the closing of the recent trading day, DexCom (DXCM) stood at $122.17, denoting a -0.51% change from the preceding trading day. |
3 Reasons Why Growth Investors Shouldn't Overlook DexCom (DXCM)DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials. |
DXCM Price Returns
1-mo | 20.63% |
3-mo | 12.10% |
6-mo | 49.10% |
1-year | 22.07% |
3-year | 59.27% |
5-year | 367.20% |
YTD | 12.10% |
2023 | 9.58% |
2022 | -15.64% |
2021 | 45.23% |
2020 | 69.02% |
2019 | 82.59% |
Continue Researching DXCM
Want to do more research on Dexcom Inc's stock and its price? Try the links below:Dexcom Inc (DXCM) Stock Price | Nasdaq
Dexcom Inc (DXCM) Stock Quote, History and News - Yahoo Finance
Dexcom Inc (DXCM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...